Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

carvedilol

Known as: (+-)-1-(Carbazol-4-yloxy)-3-((2-(O-methoxyphenoxy)ethyl)amino)-2-propanol, Carvedilolum, carvedilol [Chemical/Ingredient] 
A synthetic antihypertensive methoxyphenoxy- 2-propanol derivative with no intrinsic sympathomimetic activity, Carvedilol acts as a nonselective beta… Expand
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2013
Highly Cited
2013
OBJECTIVES This study sought to evaluate the efficacy of enalapril and carvedilol to prevent chemotherapy-induced left… Expand
  • table 1
  • table 2
  • figure 1
  • table 3
  • figure 2
Is this relevant?
Highly Cited
2006
Highly Cited
2006
OBJECTIVES The aim of this study was to determine the protective effect of carvedilol in anthracycline (ANT)-induced… Expand
Is this relevant?
Highly Cited
2004
Highly Cited
2004
CONTEXT Beta-blockers have been shown to decrease cardiovascular risk in patients with hypertension and type 2 diabetes mellitus… Expand
  • figure 1
  • table 1
  • table 2
  • figure 2
  • table 3
Is this relevant?
Highly Cited
2003
Highly Cited
2003
BACKGROUND Beta blockers reduce mortality in patients who have chronic heart failure, systolic dysfunction, and are on background… Expand
  • figure 1
  • table 1
  • figure 2
  • figure 3
  • table 2
Is this relevant?
Highly Cited
2003
Highly Cited
2003
OBJECTIVES We sought to evaluate the effects of carvedilol on mortality and morbidity in dialysis patients with dilated… Expand
  • table 1
  • table 2
  • table 3
  • figure 1
  • figure 2
Is this relevant?
Highly Cited
2002
Highly Cited
2002
BACKGROUND Beta-blocking agents improve functional status and reduce morbidity in mild-to-moderate heart failure, but it is not… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • table 1
Is this relevant?
Highly Cited
2001
Highly Cited
2001
BACKGROUND Beta-blocking agents reduce the risk of hospitalization and death in patients with mild-to-moderate heart failure, but… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
Highly Cited
2001
Highly Cited
2001
BACKGROUND The beneficial effects of beta-blockers on long-term outcome after acute myocardial infarction were shown before the… Expand
Is this relevant?
Highly Cited
1996
Highly Cited
1996
BACKGROUND Controlled clinical trials have shown that beta-blockers can produce hemodynamic and symptomatic improvement in… Expand
Is this relevant?
Highly Cited
1996
Highly Cited
1996
BACKGROUND We conducted a multicenter, placebo-controlled trial designed to establish the efficacy and safety of carvedilol, a… Expand
Is this relevant?